NCT06733363
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
- Locations
-
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
Clinical trial condition
Non-Muscle Invasive Bladder Carcinoma
Explore clinical trials studying Non-Muscle Invasive Bladder Carcinoma. Study availability and eligibility vary by location and protocol.
7 public trials
4 recruiting studies
Non-Muscle Invasive Bladder Carcinoma trial results
NCT07480356
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Carcinoma in Situ, +16 more
- Locations
-
- East Valley Urology Center of Arizona Queen Creek, Arizona, United States
- Arkansas Urology Little Rock, Arkansas, United States
- Michael Oefelein Clinical Trials Bakersfield, California, United States
- Renown Regional Medical Center St Louis, Missouri, United States
NCT06704191
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT07474519
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Not yet recruiting
Feasibility of HISA During TURBT for NMIBC
NCT07817173
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy), Bladder Cancer, Bladder Cancer (BC), +20 more
- Locations
-
- Charleston Area Medical Center Memorial Hospital Charleston, West Virginia, United States
Not yet recruiting
A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
NCT07725796
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +20 more
- Locations
-
- East Valley Urology Center of Arizona Queen Creek, Arizona, United States
- Michael G Oefelein Clinical Trials Bakersfield, California, United States
- Urology Center of Southern California Murrieta, California, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
Active, not recruiting
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
NCT05483868
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
- Locations
-
- Arkansas Urology Little Rock, Arkansas, United States
- Tower Urology Los Angeles, California, United States
- Saint John's Cancer Institute Santa Monica, California, United States
- Montefiore Medical Center The Bronx, New York, United States